M. Ray

Agonist‐induced morphologic decrease in cellular d1A dopamine receptor staining

D. Sibley, M. Levine, K. Altemus, 1997, Synapse.

Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [125I]α-conotoxinMII in the striatum and thalamus

E. Perry, D. Guilloteau, R. Perry, 2005, Experimental Neurology.

Neuronal nicotinic acetylcholine receptor subunits in autism: an immunohistochemical investigation in the thalamus

E. Perry, R. Perry, J. Court, 2005, Neurobiology of Disease.

Evaluation of the role of melatonin in formalin-induced pain response in mice.

P. Mediratta, P. Mahajan, K. Sharma, 2004, Indian journal of medical sciences.

Human brain nicotinic receptors, their distribution and participation in neuropsychiatric disorders.

J. Court, T. Teaktong, J A Court, 2002, Current drug targets. CNS and neurological disorders.

Receptor mechanisms involved in the anticonvulsant effect of melatonin in maximal electroshock seizures.

K. Reeta, P. Mediratta, P. Mahajan, 2004, Methods and findings in experimental and clinical pharmacology.

Involvement of α6/α3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [125I]-α-conotoxin MII binding in the thalamus and striatum.

E. Perry, I. McKeith, C. Ballard, 2004, Neuroscience Letters.

Differential nicotinic acetylcholine receptor subunit expression in the human hippocampus

E. Perry, R. Perry, E. Jaros, 2003, Journal of Chemical Neuroanatomy.